8-Year Safety and Efficacy of Long-Acting GH Therapy in Pediatric IGHD II with Chiari Malformation Type 1: A Case Report with Review of Literature
{{output}}
Isolated growth hormone deficiency Type II (IGHD II) is a rare autosomal dominant disorder caused by heterozygous GH1 gene mutations. Recombinant human GH (rhGH) has long been the standard therapy, but long-term real-world data on long-acting GH (LAGH) in pati... ...
